IMAC Holdings Inc
BACK
$0.180 0.00%
Exchange: NASDAQ | Sector: Healthcare | Industry: Medical Care Facilities
Q3 2024
Published: Jan 17, 2025

Earnings Highlights

  • Revenue of $0.06M down 96.4% year-over-year
  • EPS of $-1.56 increased by 40.7% from previous year
  • Gross margin of -116.8%
  • Net income of -2.20M
  • ""We are implementing broader operational efficiencies and strategically expanding our service offerings to bolster the revenue streams."" - IMAC Holdings Management
BACK
IMAC Holdings Inc

Executive Summary

In Q3 2024, IMAC Holdings Inc (NASDAQ: BACK) reported significant financial challenges, reflecting ongoing pressures in the healthcare sector, specifically within regenerative medicine. The company experienced total revenues of $56,300, showcasing a sharp decrease of 96.40% year-over-year. This decline highlights the robust competition and operational inefficiencies faced by IMAC as it continues its efforts toward recovery. With a loss of $2,204,648 in net income and a negative EPS of $1.56, the financials signal pressing headwinds that are alarming for investors, despite increases in cash flow activities from reducing operational expenses and restructuring efforts.

The company attributed these results to elevated labor costs and reduced patient volumes that have greatly affected profitability. Management remains focused on strategic initiatives to enhance operational efficiency and expand service offerings, reaffirming their commitment to long-term recovery and growth in the face of adversity.

Key Performance Indicators

Revenue
Decreasing
56.30K
QoQ: 257.46% | YoY: -96.40%
Gross Profit
Decreasing
-65.78K
-1.17% margin
QoQ: -16.93% | YoY: -110.06%
Operating Income
Increasing
-2.00M
QoQ: -42.38% | YoY: 31.11%
Net Income
Increasing
-2.20M
QoQ: -59.36% | YoY: 24.31%
EPS
Increasing
-1.56
QoQ: -33.33% | YoY: 40.68%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q1 2025 0.00 -1.08 +0.0% View
Q4 2024 0.15 -3.22 +103.0% View
Q3 2024 0.06 -1.56 -96.4% View
Q2 2024 0.02 -1.17 -98.8% View
Q1 2024 0.00 -0.35 +0.0% View